Quantitative Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Quantitative Investment Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-15,000	Closed	-$17K	–	876
2018 Q4	$17K	Buy	+15,000	New	+$27K	﹤0.01%	535
2018 Q3	–	Sell	-25,900	Closed	-$49K	–	937
2018 Q2	$49K	Sell	25,900 -2,700	-9%	-$5.46K	﹤0.01%	701
2018 Q1	$60K	Buy	+28,600	New	+$61.3K	﹤0.01%	714
2017 Q4	–	Sell	-46,400	Closed	-$61K	–	915
2017 Q3	$61K	Buy	+46,400	New	+$57.6K	﹤0.01%	656
2017 Q1	–	Sell	-205,700	Closed	-$277K	–	963
2016 Q4	$277K	Buy	205,700 +153,600	+295%	+$201K	0.01%	738
2016 Q3	$81K	Buy	+52,100	New	+$80K	﹤0.01%	647
2016 Q2	–	Sell	-30,100	Closed	-$158K	–	972
2016 Q1	$158K	Buy	+30,100	New	+$184K	0.01%	717
2015 Q4	–	Sell	-10,100	Closed	-$85K	–	887
2015 Q3	$85K	Sell	10,100 -800	-7%	-$7.38K	0.01%	642
2015 Q2	$119K	Buy	+10,900	New	+$140K	0.02%	411
2014 Q4	–	Sell	-12,900	Closed	-$173K	–	610
2014 Q3	$173K	Buy	+12,900	New	+$154K	0.03%	303

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Quantitative Investment Management's INFI Position: Q1 2019 in Review

Quantitative Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2019, closing a stake of 15,000 shares — an estimated $17K sold.

Quantitative Investment Management first reported a position in INFI in Q3 2014 and held it in 10 quarters. The position peaked at $277K in Q4 2016. 63 funds tracked by Wall St. Rank hold INFI as of Q1 2019.

Quantitative Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
Quantitative Investment Management sold 15,000 Infinity Pharmaceuticals, Inc. shares in Q1 2019, an estimated $17K.
Quantitative Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and held it in 10 quarters.
Quantitative Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $277K in Q4 2016.
63 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2019.

Based on Quantitative Investment Management's 13F filing for Q1 2019, filed 15 May 2019.